Vaccine Renaissance Conference at the Institute for Immunology and Informatics

University Of Rhode Island, Kingston RI

Investigators

Linked publications & trials

Abstract

DESCRIPTION (provided by applicant): Given the emergence of novel infectious diseases such as avian influenza H7N9, the persistence of neglected tropical diseases and unremitting concerns about bio-terrorism, it is imperative for vaccine researchers to have the opportunity to discuss the latest advances in vaccinology, learn new methods to accelerate vaccine research, and establish inter-disciplinary and inter-institutional collaborations. The Vaccine Renaissance conference is a unique, high-quality and independently-funded (non-commercial) vaccine conference hosted by the Institute of Immunology and Informatics (iCubed) at the University of Rhode Island, and has provided international, national and regional vaccine developers with an important opportunity to share their research and establish interdisciplinary collaborations at seven successful events over the past decade. The primary objective of the Vaccine Renaissance Conference is to continue to provide a unique interactive forum for the discussion of cutting-edge vaccine research, including new tools and techniques for accelerating vaccine discovery. The secondary objective is to provide academic researchers, vaccine industry leaders and students of vaccinology with an opportunity to discuss potential collaborations. Consistent with these objectives, the conference includes content tracks focusing on biodefense, global health, novel vaccine approaches, new vaccine delivery vehicles and adjuvants, and cutting-edge vaccine-related immunology research. In addition, the conference features 'hands-on' training in immunoinformatics and bench-based techniques in sessions that are hosted within the laboratories of the Institute. To expand the reach of the conference and make the resulting discussions more accessible, an annual 'Proceedings' that features reviews and original research by the participants is published in the highly regarded journal Human Vaccines and Immunotherapeutics. Seven successful, well-attended conferences have taken place to date, opening new perspectives in vaccine research while also enabling a wide range of researchers including many women and minority trainees to interact with established vaccinologists. In the current proposal, we propose to extend this unique, highly successful and interactive conference for five more years, from 2014 through 2018.